Home
Conditions
Hepatocellular Carcinoma (HCC)

Clinical trial condition

Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

243 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma (HCC) trial results

Recruiting

Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma

NCT07413354

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan 430030, Hubei, China Wuhan, Hubei, China

View Trial Details

Recruiting

Computer Guided Microwave Liver Ablation

NCT07226869

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dartmouth HItchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Recruiting

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

NCT07150624

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Anhui Provincial Hospital Hefei, Anhui, China

View Trial Details

Recruiting

DEB-TACE vs cTACE in HCC After TIPS

NCT07322848

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: The First Affiiated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

NCT07075120

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The Queen's Medical Center Honolulu, Hawaii, United States

University of Hawai'i Cancer Center Honolulu, Hawaii, United States

View Trial Details

Recruiting

A Prospective, Randomized Study of TACE Combined With Sintilimab, Bevacizumab, and Ipilimumab N01 Treating Advanced HCC

NCT07422753

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: the Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)

NCT06860490

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma

NCT07538882

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Beijing Tsinghua Changgung Hospital Beijing, Changping, China

View Trial Details

Recruiting

Scout Dose of Resin Microspheres

NCT07476651

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.

NCT07490262

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The First Affiliated Hosptial of USTC Hefei, Anhui, China

Zhongshan Hospital, Fudan university Shanghai, Shanghai Municipality, China

View Trial Details

Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC) trial results

Related conditions